Castle Biosciences Raises FY2026 Sales Guidance from $365.000M-$375.000M to $385.000M-$395.000M vs $373.753M Est
Benzinga Newsdesk 1 day ago
NewsGuidance
Castle Biosciences (NASDAQ:CSTL) raises FY2026 sales outlook from $365.000 million-$375.000 million to $385.000 million-$395.000 million vs $373.753 million estimate.
Castle Biosciences (NASDAQ:CSTL) raises FY2026 sales outlook from $365.000 million-$375.000 million to $385.000 million-$395.000 million vs $373.753 million estimate.